See which companies suffered the worst clinical setbacks in the week ending May 2.
News & Analysis: OncoGenex Pharmaceuticals
OncoGenex got crushed today. Is there some light at the end of the tunnel?
Johnson & Johnson's abiraterone looks good, but won't knock off the newcomer.
Johnson & Johnson made a good choice to purchase Cougar Biotechnology.